• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.13% Nasdaq Up0.70%

    Opexa Therapeutics, Inc. (OPXA)

    -NasdaqCM
    0.81 Up 0.01(1.26%) Dec 26, 3:55PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 308   308   349   349  
    Cost of Revenue -   -   -   -  
    Gross Profit 308   308   349   349  
    Operating Expenses
    Research Development3,174  3,409  2,811  2,842  
    Selling General and Administrative917  967  1,103  1,191  
    Non Recurring -   -   -   -  
    Others97  99  96  77  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (3,881) (4,168) (3,661) (3,764)
    Income from Continuing Operations
    Total Other Income/Expenses Net3  4  5  3  
    Earnings Before Interest And Taxes(3,877)(4,163)(3,656)(3,761)
    Interest Expense1   -   -  0  
    Income Before Tax(3,878)(4,163)(3,656)(3,761)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(3,878)(4,163)(3,656)(3,761)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (3,878) (4,163) (3,656) (3,758)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (3,878) (4,163) (3,656) (3,758)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.